Sanofi Stalls Generic Plavix Launch In Germany

Law360, New York (July 17, 2008, 12:00 AM EDT) -- The launch of a generic version of the blockbuster blood-thinning drug Plavix will be delayed in Germany until the German government can sort out a challenge from Plavix maker Sanofi-Aventis SA.

Andreas Rummelt, the chief executive of Novartis AG's Sandoz generics division, announced the delay Thursday during the company's half-year results update.

Novartis' Sandoz, along with a privately held German firm, is set to sell the Plavix generic under a distribution agreement with Schweizerhall Holding Ltd., a Swiss-based pharmaceutical company, Dow Jones reported.

The German Federal...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.